{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:06:58Z","timestamp":1779772018392,"version":"3.53.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146693","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T01:57:36Z","timestamp":1754618256000},"page":"146693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Site-specific characterization of mannose-6-phosphate-containing N-glycans on recombinant idursulfase beta for lysosomal targeting in Hunter syndrome therapy"],"prefix":"10.1016","volume":"322","author":[{"given":"Byoungju","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyoon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mijung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeungwoon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulmin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha Hyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.146693_bb0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/21678707.2013.738182","article-title":"Evaluation of idursulfase for the treatment of mucopolysaccharidosis II (Hunter syndrome)","volume":"1","author":"Scarpa","year":"2013","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0010","series-title":"The Online Metablic and Molcular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2019"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13052-024-01769-9","article-title":"The diagnosis and management of mucopolysaccharidosis type II","volume":"50","author":"Mao","year":"2024","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II - a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-42","article-title":"Phase I\/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (hunter syndrome)","volume":"8","author":"Sohn","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0035","doi-asserted-by":"crossref","first-page":"2408402","DOI":"10.1155\/2020\/2408402","article-title":"Mucopolysaccharidoses I and II: brief review of therapeutic options and supportive\/palliative therapies","volume":"2020","author":"Nan","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/eng2.12271","article-title":"Idursulfase pharmacokinetics, cellular uptake, and pharmacodynamics: effect of sialylation and manufacturing process","volume":"2","author":"Garcia","year":"2020","journal-title":"Eng. Reports"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrm1050","article-title":"Mannose 6-phosphate receptors: new twists in the tale","volume":"4","author":"Ghosh","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.bi.61.070192.001515","article-title":"Structure and function of the mannose 6-phosphate\/insulinlike growth factor II receptors","volume":"61","author":"Kornfeld","year":"1992","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.aca.2016.03.049","article-title":"Glycan characterization of biopharmaceuticals: updates and perspectives","volume":"921","author":"Planinc","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0065","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/glycob\/cwv065","article-title":"Fc glycans of therapeutic antibodies as critical quality attributes","volume":"25","author":"Reusch","year":"2015","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jchromb.2019.04.031","article-title":"Glycan analysis for protein therapeutics","volume":"1120","author":"Yang","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0075","first-page":"1","article-title":"Fundamentals and advances of Orbitrap mass spectrometry","author":"Hecht","year":"2019","journal-title":"Encyclop. Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0080","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1021\/acs.analchem.5b00758","article-title":"Rapid preparation of released N-glycans for HILIC analysis using a labeling reagent that facilitates sensitive fluorescence and ESI-MS detection","volume":"87","author":"Lauber","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0085","first-page":"1062","article-title":"Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study","volume":"31","author":"Deri\u0161","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fchem.2018.00324","article-title":"Comparison of 2-aminobenzamide, procainamide and RapiFluor-MS as derivatizing agents for high-throughput HILIC-UPLC-FLR-MS N-glycan analysis","volume":"6","author":"Keser","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0095","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1039\/b713816d","article-title":"Glycopeptide analysis by mass spectrometry","volume":"133","author":"Dalpathado","year":"2008","journal-title":"Analyst"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0100","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s13361-011-0273-y","article-title":"Detection and characterization of low abundance glycopeptides via higher-energy C-trap dissociation and Orbitrap mass analysis","volume":"23","author":"Hart-Smith","year":"2012","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S1044-0305(03)00263-0","article-title":"Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning","volume":"14","author":"Jebanathirajah","year":"2003","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0110","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.R120.002090","article-title":"Recent advances in software tools for more generic and precise intact glycopeptide analysis","volume":"20","author":"Cao","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/19768354.2022.2079719","article-title":"Mannose-6-phosphate glycan for lysosomal targeting: various applications from enzyme replacement therapy to lysosome-targeting chimeras","volume":"26","author":"Seo","year":"2022","journal-title":"Anim. Cells Syst."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ymgme.2013.12.296","article-title":"Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes","volume":"111","author":"Togawa","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijms.2011.06.017","article-title":"Mass spectrometry-based characterization of acidic glycans on protein therapeutics","volume":"312","author":"Salinas","year":"2012","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0130","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1021\/acs.analchem.0c00661","article-title":"Impact of glycosylation on the comparability of the higher-order structures in idursulfase by hydrogen-deuterium exchange mass spectrometry","volume":"92","author":"Barton","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10719-014-9523-0","article-title":"A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome","volume":"31","author":"Chung","year":"2014","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0140","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.bbrc.2017.12.101","article-title":"Four unreported types of glycans containing mannose-6-phosphate are heterogeneously attached at three sites (including newly found Asn 233) to recombinant human acid alpha-glucosidase that is the only approved treatment for Pompe disease","volume":"495","author":"Park","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123538","article-title":"Peptide-N-glycosidase F or A treatment and procainamide-labeling for identification and quantification of N-glycans in two types of mammalian glycoproteins using UPLC and LC-MS\/MS","volume":"1214","author":"Kim","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/polym13010103","article-title":"N-glycan modifications with negative charge in a natural polymer mucin from bovine submaxillary glands, and their structural role","volume":"13","author":"Kim","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0155","article-title":"Surface plasmon resonance analysis of complex formation of therapeutic recombinant lysosomal enzymes with domain 9 of human cation-independent mannose 6-phosphate receptor","volume":"25","author":"Kanzaki","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/jhg.2016.133","article-title":"Comparative study of idursulfase beta and idursulfase in vitro and in vivo","volume":"62","author":"Kim","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0165","doi-asserted-by":"crossref","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of \u03b1-galactosidase a in human podocytes in Fabry disease","volume":"6","author":"Prabakaran","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/excr.2002.5651","article-title":"Human heparanase is localized within lysosomes in a stable form","volume":"281","author":"Goldshmidt","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0175","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1021\/acs.analchem.0c05203","article-title":"Using hybrid organic-inorganic surface technology to mitigate analyte interactions with metal surfaces in UHPLC","volume":"93","author":"Delano","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462247","article-title":"Mitigation of analyte loss on metal surfaces in liquid chromatography","volume":"1650","author":"Gilar","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123120","article-title":"High sensitivity acidic N-glycan profiling with MS-enhancing derivatization and mixed mode chromatography","volume":"1191","author":"Liu","year":"2022","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0190","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0076-6879(06)16011-5","article-title":"Lectin-resistant CHO glycosylation mutants","volume":"416","author":"Patnaik","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/glycob\/cwg018","article-title":"Activities and expression pattern of the carbohydrate sulfotransferase GlcNAc6ST-3 (I-GlcNAc6ST): functional implications","volume":"13","author":"Lee","year":"2003","journal-title":"Glycobiology"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0200","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/elps.201100231","article-title":"Harnessing glycomics technologies: integrating structure with function for glycan characterization","volume":"33","author":"Robinson","year":"2012","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1451512","article-title":"Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease","volume":"15","author":"Byrne","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0210","doi-asserted-by":"crossref","first-page":"7962","DOI":"10.1016\/S0021-9258(18)83136-2","article-title":"Ligand interactions of the cation-independent mannose 6-phosphate receptor","volume":"264","author":"Tong","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146693_bb0215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025072502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025072502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:00:31Z","timestamp":1779771631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025072502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S0141813025072502"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146693","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-specific characterization of mannose-6-phosphate-containing N-glycans on recombinant idursulfase beta for lysosomal targeting in Hunter syndrome therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146693"}}